Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Suspended 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 2Breast 1

Conditions

Prostatic Neoplasms 6268Carcinoma, Renal Cell 1913Urinary Bladder Neoplasms 1670Kidney Neoplasms 930Breast Neoplasms 793Neoplasms 788Carcinoma, Transitional Cell 594Carcinoma, Non-Small-Cell Lung 524Neoplasm Metastasis 510Melanoma 485Ovarian Neoplasms 468Colorectal Neoplasms 454Lung Neoplasms 435Pancreatic Neoplasms 325Testicular Neoplasms 290Stomach Neoplasms 274Sarcoma 267Uterine Cervical Neoplasms 264Non-Muscle Invasive Bladder Neoplasms 263Head and Neck Neoplasms 241Colonic Neoplasms 217Esophageal Neoplasms 203Squamous Cell Carcinoma of Head and Neck 202Carcinoma, Hepatocellular 197Wilms Tumor 196Endometrial Neoplasms 189Recurrence 162Neuroblastoma 148Urologic Neoplasms 147Small Cell Lung Carcinoma 146

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Dysuria × Genitourinary × Clear all
NCT05148156 2026-01-27

Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.

Northwell Health

Phase NA Suspended
20 enrolled
Genitourinary

Prostatic Hyperplasia, Nocturia, Dysuria

NCT01563796 2025-09-26

Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer

Medical Diagnostic Laboratories, LLC

Terminated
1,115 enrolled
Genitourinary

Urinary Bladder Neoplasms, Hematuria, Dysuria

Data powered by HemOnc (CC BY 4.0) Colophon âš¡